Here's What Key Metrics Tell Us About Northrop Grumman (NOC) Q4 Earnings
Werte in diesem Artikel
Northrop Grumman (NOC) reported $10.69 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 0.5%. EPS of $6.39 for the same period compares to $6.27 a year ago.The reported revenue represents a surprise of -3.09% over the Zacks Consensus Estimate of $11.03 billion. With the consensus EPS estimate being $6.27, the EPS surprise was +1.91%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Northrop Grumman performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Sales- Mission Systems: $3.14 billion compared to the $3.24 billion average estimate based on six analysts. The reported number represents a change of +2.6% year over year. Sales- Aeronautics Systems: $3.22 billion compared to the $3.20 billion average estimate based on six analysts. The reported number represents a change of +10.7% year over year. Sales- Intersegment eliminations: -$721 million versus the six-analyst average estimate of -$728.36 million. The reported number represents a year-over-year change of +23.9%. Sales- Space Systems: $2.71 billion compared to the $2.74 billion average estimate based on six analysts. The reported number represents a change of -24.8% year over year. Sales- Defense Systems: $2.33 billion compared to the $2.58 billion average estimate based on six analysts. The reported number represents a change of +41.8% year over year. Operating income (loss)- Intersegment eliminations: -$95 million compared to the -$97.01 million average estimate based on six analysts. Operating income (loss)- Defense Systems: $252 million compared to the $264.46 million average estimate based on six analysts. Operating income (loss)- Mission Systems: $469 million versus the six-analyst average estimate of $457.72 million. Operating income (loss)- Space Systems: $275 million versus the six-analyst average estimate of $281.02 million. Operating income (loss)- Aeronautics Systems: $292 million compared to the $312.28 million average estimate based on six analysts. Segment operating income adjustment- Unallocated corporate expenses: -$112 million versus the five-analyst average estimate of -$93.95 million. Segment operating income adjustment- FAS/CAS operating adjustment: $8 million compared to the -$5.89 million average estimate based on four analysts. View all Key Company Metrics for Northrop Grumman here>>>Shares of Northrop Grumman have returned +2.6% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Northrop Grumman Corporation (NOC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Northrop Grumman
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Northrop Grumman
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Northrop Grumman Corp.
Analysen zu Northrop Grumman Corp.
Datum | Rating | Analyst | |
---|---|---|---|
29.03.2018 | Northrop Grumman Overweight | Barclays Capital | |
26.10.2017 | Northrop Grumman Outperform | RBC Capital Markets | |
12.01.2017 | Northrop Grumman Outperform | RBC Capital Markets | |
10.11.2016 | Northrop Grumman Overweight | Barclays Capital | |
06.10.2016 | Northrop Grumman Outperform | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
29.03.2018 | Northrop Grumman Overweight | Barclays Capital | |
26.10.2017 | Northrop Grumman Outperform | RBC Capital Markets | |
12.01.2017 | Northrop Grumman Outperform | RBC Capital Markets | |
10.11.2016 | Northrop Grumman Overweight | Barclays Capital | |
06.10.2016 | Northrop Grumman Outperform | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
19.05.2016 | Northrop Grumman Sector Perform | RBC Capital Markets | |
02.05.2016 | Northrop Grumman Equal Weight | Barclays Capital | |
30.04.2015 | Northrop Grumman Neutral | UBS AG | |
12.02.2015 | Northrop Grumman Equal Weight | Barclays Capital | |
19.10.2012 | Northrop Grumman perform | Oppenheimer & Co. Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
13.09.2012 | Northrop Grumman sell | UBS AG | |
14.06.2006 | Update Northrop Grumman Corp.: Underperform | Goldman Sachs |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Northrop Grumman Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen